The membrane proximal external region (MPER) of the HIV-1 glycoprotein gp41 is targeted by the broadly neutralizing antibodies 2F5 and 4E10. To date, no immunization regimen in animals or humans has produced HIV-1 neutralizing MPER-specific antibodies. We immunized llamas with gp41-MPER proteoliposomes and selected a MPER-specific single chain antibody (VHH), 2H10, whose epitope overlaps with that of mAb 2F5. Bi-2H10, a bivalent form of 2H10, which displayed an approximately 20-fold increased affinity compared to the monovalent 2H10, neutralized various sensitive and resistant HIV-1 strains, as well as SHIV strains in TZM-bl cells. X-ray and NMR analyses combined with mutagenesis and modeling revealed that 2H10 recognizes its gp41 epitope i...
International audiencePotent and broadly neutralizing antibodies (bnAbs) are the hallmark of HIV-1 p...
SummaryAlthough rarely elicited during natural human infection, the most broadly neutralizing antibo...
SummaryBroadly neutralizing monoclonal antibodies to HIV-1 are rare but invaluable for vaccine desig...
The membrane proximal external region (MPER) of the HIV-1 glycoprotein gp41 is targeted by the broad...
International audienceThe membrane proximal external region (MPER) of the HIV-1 glycoprotein gp41 is...
International audienceThe membrane proximal external region (MPER) of the HIV-1 glycoprotein gp41 is...
<div><p>The membrane proximal external region (MPER) of the HIV-1 glycoprotein gp41 is targeted by t...
International audienceThe membrane proximal external region (MPER) of the HIV-1 glycoprotein gp41 is...
International audienceThe membrane proximal external region (MPER) of the HIV-1 glycoprotein gp41 is...
International audienceThe membrane proximal external region (MPER) of the HIV-1 glycoprotein gp41 is...
The membrane proximal external region (MPER) of the HIV-1 glycoprotein gp41 is targeted by the broad...
AbstractThe membrane-proximal external region (MPER) of gp41 is considered as a prime target for the...
Broadly neutralizing antibodies are not commonly produced in HIV-1 infected individuals nor by exper...
Broadly neutralizing antibodies are not commonly produced in HIV-1 infected individuals nor by exper...
AbstractThe membrane-proximal external region (MPER) of HIV-1 gp41 is an attractive target for vacci...
International audiencePotent and broadly neutralizing antibodies (bnAbs) are the hallmark of HIV-1 p...
SummaryAlthough rarely elicited during natural human infection, the most broadly neutralizing antibo...
SummaryBroadly neutralizing monoclonal antibodies to HIV-1 are rare but invaluable for vaccine desig...
The membrane proximal external region (MPER) of the HIV-1 glycoprotein gp41 is targeted by the broad...
International audienceThe membrane proximal external region (MPER) of the HIV-1 glycoprotein gp41 is...
International audienceThe membrane proximal external region (MPER) of the HIV-1 glycoprotein gp41 is...
<div><p>The membrane proximal external region (MPER) of the HIV-1 glycoprotein gp41 is targeted by t...
International audienceThe membrane proximal external region (MPER) of the HIV-1 glycoprotein gp41 is...
International audienceThe membrane proximal external region (MPER) of the HIV-1 glycoprotein gp41 is...
International audienceThe membrane proximal external region (MPER) of the HIV-1 glycoprotein gp41 is...
The membrane proximal external region (MPER) of the HIV-1 glycoprotein gp41 is targeted by the broad...
AbstractThe membrane-proximal external region (MPER) of gp41 is considered as a prime target for the...
Broadly neutralizing antibodies are not commonly produced in HIV-1 infected individuals nor by exper...
Broadly neutralizing antibodies are not commonly produced in HIV-1 infected individuals nor by exper...
AbstractThe membrane-proximal external region (MPER) of HIV-1 gp41 is an attractive target for vacci...
International audiencePotent and broadly neutralizing antibodies (bnAbs) are the hallmark of HIV-1 p...
SummaryAlthough rarely elicited during natural human infection, the most broadly neutralizing antibo...
SummaryBroadly neutralizing monoclonal antibodies to HIV-1 are rare but invaluable for vaccine desig...